You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

Pacific Rim Summit to Highlight Novel Biotech Applications for Bioenergy

WASHINGTON, D.C. (Thursday, September 24, 2009) - Biotechnology companies pursuing new sources of bioenergy and green products will highlight the industry’s progress at the 2009 Pacific Rim Summit on Industrial Biotechnology and Bioenergy, to be held Nov. 8-11, 2009 in Honolulu. The Biotechnology Industry Organization (BIO) today announced speakers for the plenary sessions to be delivered at the 2009 Pacific Rim Summit.

“Development of biotechnology applications for energy and chemicals has been shown to both reduce carbon emissions and provide opportunities for renewed economic growth. As the world emerges from the current economic recession, biotechnology companies are seeking to regain momentum in bringing advanced biofuels to market. Construction of the first advanced biofuel biorefineries is providing valuable knowledge and technology platforms for new chemicals and other sources of bioenergy, including algae,”said Brent Erickson, executive vice president of BIO’s Industrial and Environmental Section.

Plenary sessions scheduled for the Pacific Rim Summit include (all times indicated are in Hawaii-Aleutian Standard Time):

Asia-Pacific Advances in Industrial Biotechnology
Monday, Nov. 9, 11:45 a.m. – 1:45 p.m.

·         Nobuyuki Kawashima, Executive Director-Elect, The Chemical Society of Japan

·         Bhima Vijayendran, Chief Research Officer, Renewable Energy Laboratory, Malaysia

 

Advanced Biofuels: Status of Commercialization Efforts
Tuesday, Nov. 10, 7:45 a.m. – 9:15 a.m.

·         Patrick R. Gruber, Ph.D., CEO, Gevo, Inc.

·         Alan Shaw, CEO, Codexis

·         Joel Velasco, Chief Representative, North America, UNICA (Brazilian Sugar Cane Industry Association)

 

Novel Applications in the Industrial Biotechnology Space
Tuesday, Nov. 10, 1:00 p.m. – 3:15 p.m.

·         Phil Hendry, Genomics Research Program Leader, CSIRO, Australia

·         Kevin A. Jarrell, President and CEO, Modular Genetics

·         Bill Sims, CEO, Joule Biotechnologies

 

The Business of Engineering Life
Wednesday, Nov. 11, 7:15 a.m. – 8:45 a.m.

·         Rob Carlson, Principal, Biodesic

 

Algae Production Systems: Opportunities and Challenges
Wednesday, Nov. 11, 12:00 p.m. – 2:00 p.m.

·         Ron Pate, Principal Member of Technical Staff , Energy, Resources, and Systems Analysis Center, Sandia National Laboratories

·         Edward Shonsey, CEO, HR BioPetroleum

·         Craig Smith, M.D., Executive Vice President, Chief Operating Officer, Algenol

 

The full schedule for the conference is available at http://www.bio.org/pacrim/speakers/speakers.asp.

All programs at the Pacific Rim Summit on Industrial Biotechnology and Bioenergy are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials. Advance media registration is now open; please use the online tool to register: http://www.bio.org/news/pressreg/mediareg.asp?multievent=31. Notification of your registration status will be emailed to you, based on the information posted in this online form.

Upcoming BIO Events

BIO Investor Forum
October 28-29, 2009
San Francisco, CA

Advanced Business Development Course
October 30, 2009
Vienna, Austria

BIO Europe International Partnering Conference
November 2-4, 2009
Vienna, Austria

Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 8-11, 2009
Honolulu, HI 

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

###